1. Introduction {#sec1}
===============

Systems biology typically uses networks to model and discover emergent properties among genes, proteins, and other relevant biomolecules referred to specific phenotypes or diseases.

Theoretical studies have revealed that biological networks share many features with other types of networks such as computer or social networks. They enable the application of several mathematical and computational methods of the graph theory to biological studies \[[@B1], [@B2]\]. The computational analysis of biological networks has therefore become increasingly used to mine the complexity of cellular processes and signaling pathways.

Many types of biological networks do exist, depending on the information associated to their nodes and edges. In general, they can be classified as directed or undirected networks \[[@B3]\]. In directed networks, nodes are molecules, while edges indicate causal biological interactions among nodes (e.g., transcription and translation regulations \[[@B4]\]). Instead, in undirected networks, an edge indicates a shared property, such as sequence similarity \[[@B5]\], gene coexpression \[[@B6]--[@B9]\], protein-protein interaction \[[@B10]\], or term cooccurrence in the scientific literature \[[@B11]--[@B13]\].

Undirected gene coexpression networks, coupled with efficient computational algorithms and complemented by the literature mining, may represent a valuable instrument to identify relevant information (e.g., biomarkers) for a particular disease. However, coexpression networks built from experimental expression data are in general large highly connected networks with an elevated number of false-positive interactions (nodes and edges). In order to infer relevant information, the network must be properly filtered and its complexity reduced. Given the complexity and the multivariate nature of the information contained in the network, this requires the development and application of efficient feature selection algorithms to be able to exploit the network topological characteristics.

Several feature selection algorithms have been proposed in the literature: some in the context of generic machine learning techniques \[[@B14]\] and others more specifically designed to work with transcriptome data \[[@B15]--[@B21]\]. Following Saeys et al. \[[@B21]\], feature selection methods fall in three main categories, namely, (1) filters, (2) wrappers, and (3) embedded methods.

Filters assess the relevance of features by looking at the intrinsic properties of the data. They do not consider any learning or classification model \[[@B19]\]. Filtering techniques easily scale to very high-dimensional datasets. They are computationally simple and fast, and they are independent of any machine learning model to be applied after filtering. However, a common disadvantage of filtering methods is that most of the proposed techniques are univariate \[[@B19]\], which is a major limitation for transcriptome data analysis. In fact, genes tend to work according to complex gene regulatory networks, and their expression profiles are therefore highly correlated. To overcome this limitation, multivariate filtering techniques to some extent incorporating feature dependencies have been introduced \[[@B22], [@B23]\]. Unfortunately, they are in general slower and less scalable than univariate techniques, thus preventing their application on genome-wide transcriptome data.

Wrappers \[[@B24]\] and embedded approaches \[[@B17]\] differ from filters since they are designed to work with specific machine learning and classification models. The main difference between the two groups of approaches is that in embedded approaches feature selection is built into the classifier, while wrappers work together with the classifier but are not part of it. In general, these approaches are able to improve the classification accuracy. However, different classification models may highlight different sets of relevant genes, and sometimes genes that might be biologically representative are discarded by the classification model.

In this paper, we exploit gene coexpression networks and network topological analysis to implement an efficient multivariate filtering algorithm attempting to reduce the size of the network under analysis and to identify sets of genes, which have a biological relevance for a given disease. In particular, a multiweighted coexpression network, is built on top of collected expression data in order to efficiently represent correlations among genes in high-dimensional expression datasets. A topological analysis algorithm is then applied to the coexpression network to identify regions of the network with interesting topological properties that may highlight relevant genes for the modeled phenomenon.

We tested the proposed approach on a set of microarray experiments for three well-studied diseases and compared the obtained list of relevant genes with a bibliometric correlation list of genes retrieved resorting to the ProteinQuest \[[@B25]\] tool. Statistical analysis on the obtained results highlighted that the proposed approach is able to strongly reduce the size of the analyzed coexpression networks, while keeping genes that are highly correlated with the target diseases in the scientific literature.

2. Methods and Materials {#sec2}
========================

The network filtering approach proposed in this paper includes two computational steps designed to organize the expression data into a multiweighted coexpression network that is able to better highlight relationships among nodes compared to single-weighted networks, andanalyze the multi-weighted network in order to identify regions of the network with interesting topological properties that may highlight relevant genes for the modeled phenomenon.

2.1. Multiweighted Coexpression Networks {#sec2.1}
----------------------------------------

Let us consider a dataset of expression data (e.g., microarray data) for a large number of DNA sequences tested under two different conditions (e.g., healthy tissue versus diseased tissue).

We organize the dataset in the form of a gene expression matrix GEM : *N* × *M* → *e* ~*i*,*j*~ ∈ *ℜ* with rows representing samples and columns representing genes. Each element of the matrix provides the differential expression level *e* ~*i*,*j*~ of gene *g* ~*j*~ (column *j*) in sample *s* ~*i*~ (row *i*) under the two tested conditions. Among the different ways to compute differential expression, in this paper, we exploit the (binary) logarithm of the ratio between the absolute expression of the gene in the two tested conditions (log ratio). Log ratios tend to be normally distributed \[[@B26]\] and enable to easily normalize expression levels from different samples using standard score (*z* score) normalization \[[@B27]\]: $$\begin{matrix}
{e_{i,j} = \frac{\text{lo}\text{g}_{2}\left( {eC1_{i,j}/eC2_{i,j}} \right) - \mu_{i}}{\sigma_{i}},} \\
\end{matrix}$$ where *eC*1~*i*,*j*~ and *eC*2~*i*,*j*~ represent the absolute expression of gene *g* ~*j*~ in sample *s* ~*i*~ under the conditions *C*1 and *C*2, and *μ* ~*i*~ and *σ* ~*i*~ denote the mean and the standard deviation of log ratios of all genes within sample *s* ~*i*~.

Normalized expression data can be used to build a single coexpression network enabling to easily identify genes that are coexpressed within an experiment. For our analysis we exploit a multi-weighted coexpression network (MWNET) that assigns multiple weights to the network edges to identify different forms of coexpression among genes.

An MWNET is an undirected weighted graph MWNET = (*V*, *E*, *W*), where (i)vertexes *g* ~*j*~ ∈ *V* represent genes that are differentially expressed in at least one of the available samples;(ii)edges *E*⊆*V* × *V* connect pairs of vertexes (*g* ~*j*~, *g* ~*k*~) and represent genes that are coexpressed in at least a sample;(iii)a weight function *W* assigns to each edge a vector of weights: $$\begin{matrix}
\left. W:\left( {g_{i},g_{j}} \right) \in E\mapsto{\overset{\rightarrow}{w}}_{i,j} = \left( {w_{i,j}^{\text{OO}},w_{i,j}^{\text{OS}},w_{i,j}^{\text{SO}},w_{i,j}^{\text{SS}}} \right). \right. \\
\end{matrix}$$

A gene *g* ~*j*~ is considered differentially expressed in sample *s* ~*i*~ if \|*e* ~*i*,*j*~\| \> *ε*; that is, its differential expression is greater than a given threshold required to filter residual noise in the data. If the differential expression of a gene is positive, it means the gene is overexpressed in condition *C*1 compared to condition *C*2. We denote the gene as overexpressed. In the opposite condition, that is, negative differential expression, the gene is instead denoted as silenced.

Exploiting the concept of overexpressed and silenced genes, each edge of the network is labeled with four weights associated to the four combinations of expression conditions; the pair of genes connected by the edge may assume the following: (1)  *w* ~*i*,*j*~ ^OO^ both genes over-expressed, (2)  *w* ~*i*,*j*~ ^OS^ gene *g* ~*i*~ overexpressed and *g* ~*j*~ silenced, (3)  *w* ~*i*,*j*~ ^SO^ gene *g* ~*i*~ silenced and *g* ~*j*~ over-expressed, and (4)  *w* ~*i*,*j*~ ^SS^ both genes silenced. Each weight counts how many times the pair of genes assumes the selected state in the set of samples composing the dataset.

[Figure 1](#fig1){ref-type="fig"} shortly summarizes the steps required to construct an MWNET starting from raw preprocessed expression data.

Multi-weighted coexpression networks are the first original contribution of this paper and are able to provide interesting insights about gene relations. Network edges highlight relationships among genes with the weights providing a measure of the strength and the type of the relation. Moreover, by looking at the different edges, additional information can be inferred. Genes connected with edges with high *w* ^OO^/*w* ^SS^ score (i.e., both genes over-expressed or silenced) may underly a biological behavior in which the two genes enhance/silence each other, which is a common motif in biological networks \[[@B28], [@B29]\]. Similarly genes connected with edges with high *w* ^OS^/*w* ^SO^ may identify genes connected with negative loops, which again is a common motif observed in several biological networks \[[@B29]--[@B31]\].

2.2. Network Filtering {#sec2.2}
----------------------

Multi-weighed coexpression networks built from experimental expression data are in general complex highly connected networks that contain an elevated number of false-positive interactions (edges).

The weights assigned to each edge represent a valuable information to remove interaction with low informative content.

Let us consider two candidate genes A and B connected by an edge in a network built from a set of *N* samples. A uniform weight distribution on the edge (e.g., ${\overset{\rightarrow}{w}}_{A,B} = \lbrack N/4,N/4,N/4,N/4\rbrack$) identifies a low informative interaction since genes show differentiated behaviors among the different samples. Differently, if the weights are polarized toward one of the four behaviors (e.g., ${\overset{\rightarrow}{w}}_{A,B} = \lbrack N,0,0,0\rbrack$), the informative content of the edge increases.

This consideration is exploited to build a filtering mechanism for the selected network. A relevance score (*R* ~*g*~*i*~~) defined according to the following equation is assigned to each gene *g* ~*i*~ of the network according to the following equation: $$\begin{matrix}
{R_{g_{i}} = \frac{1}{N}\sum\limits_{\forall j\, \mid \,\exists{({g_{i},g_{j}})} \in E}\left\lbrack {1 - \frac{\min\left( {\overset{\rightarrow}{w}}_{i,j} \right)}{\max\left( {\overset{\rightarrow}{w}}_{i,j} \right)}} \right\rbrack} \\
{\cdot \left\lbrack {2 \cdot \frac{\sigma\left( {\overset{\rightarrow}{w}}_{i,j} \right)}{N}} \right\rbrack\quad\forall i \in \left\lbrack {1,M} \right\rbrack.} \\
\end{matrix}$$

Equation ([3](#EEq2){ref-type="disp-formula"}) tries to assign high scores to genes that are connected to their neighbors with strong polarization. If two genes are connected with almost uniform weight distribution, the minimum and the maximum weights are similar and the first term of the equation tends to zero thus lowering the score. In all other cases, the more the edges are weighted with a not uniform distribution, the more their score increases.

The relevance score introduced by ([3](#EEq2){ref-type="disp-formula"}) is used to filter the list of nodes and edges of the network thus reducing its complexity. Setting a threshold on the acceptable relevant scores allows us to remove low relevant genes and their related edges, thus obtaining a filtered list of genes and a reduced network ready for further analyses aiming at identifying interesting network motifs \[[@B4], [@B31]--[@B34]\].

The proposed relevance score is defined in order to highlight those genes that manifest expression changes between the two considered conditions *C*1 and *C*2 in a significant number of samples of the considered data set. The quality and the numerosity of the available data are therefore the key issues to properly compute this score. This is even more critical when samples collected for a given disease include different phenotypes. If a given phenotype is not properly represented in the dataset, the risk of ranking its specific markers with low relevant scores becomes high, with the risk of losing important biological information during the filtering process that could provide unexpected leads for biologic or therapeutic insights. Nevertheless, this is a common drawback of all machine learning and statistical methods that can only be mitigated by increasing the number of collected samples and carefully selecting them in order to be representative for the considered phenomenon.

Moreover, the threshold used to filter the network is a good instrument to deal with the risk of loosing significant genes. A tight threshold will in general filter the presence of different phenotypes. It enables to obtain a smaller network representative of the common properties of the considered disease, regardless of the specific phenotypes. Instead, by relaxing the threshold, also genes that are informative in a reduced set of samples will be included in the filtered network. Researchers may look at this low ranked genes as candidates nodes that are able to highlight specific phenotypes, and therefore conduct further experimental investigations.

3. Results and Discussion {#sec3}
=========================

In our experimental design, we tested the proposed network filtering algorithm on three coexpression networks obtained from expression data for three well studied and documented diseases with available on-line datasets.*Acute Myeloid Leukemia Dataset (AML)*: peripheral-blood samples or bone marrow samples of intermediate-risk AML with a normal karyotype \[[@B35]\]. This dataset includes 14 samples with 43,196 spots (45 K technology) obtained from microarray data available at the Gene Expression Omnibus (GEO), accession number GSE426. The complete list of selected samples is available in [Table 1](#tab1){ref-type="table"}.*Breast Cancer* (BC): samples of predominantly advanced primary breast tumor \[[@B36]\]. This dataset includes 20 samples with 9,216 spots (9 K technology) obtained from microarray data available at the Gene Expression Omnibus (GEO), accession number GSE3281. The complete list of selected samples is available in [Table 2](#tab2){ref-type="table"}.*Diffuse Large B-Cell Lymphoma Dataset (DLCL)*: a set of samples from patients with diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin\'s lymphoma downloaded from a larger dataset of experiments aiming at performing Lymphoma classification \[[@B37], [@B38]\]. This dataset includes 51 samples with 9,216 spots (9 K technology) obtained from microarray data available at the Gene Expression Omnibus (GEO), accession number GSE60. The complete list of selected samples is available in [Table 3](#tab3){ref-type="table"}.

Samples have been downloaded from the cDNA Stanford Microarray database \[[@B39]\]. All genes without a valid *Unigene ID* have been discarded. The normalized differential expression for each gene has been computed according to ([1](#EEq1){ref-type="disp-formula"}) considering the CH1I_MEAN and the CH2I_MEAN mean intensity channels available for each microarray as absolute expression level of each gene, and *ε* = 0 (1-folding). Since old microarray technologies often used spots duplication, during the network generation we considered as expressed those genes differentially expressed in at least one of their replica on the microarray.

The filtering process has been executed on the three considered datasets applying a quite relaxed threshold of 0.5 on the relevance score of ([3](#EEq2){ref-type="disp-formula"}).

[Table 4](#tab4){ref-type="table"} shows the aggregated results in terms of number of genes before and after filtering, highlighting the relevant reduction ratio. The full list of identified genes is instead provided as Supplementary Material to this paper available online at <http://dx.doi.org/10.1155/2013/676328> (global_citation_summary.xlsx file---BC Filtered Genes, AML Filtered Genes and DLCL Filtered Genes sheets).

Validation of the proposed filtering algorithm has been performed by comparing the list of filtered genes with data mined from the available scientific literature. It is worth to mention here that this validation phase does not aim at identifying new markers for the considered diseases. By selecting three diseases that have been intensively studied and documented, we aim at confirming how the proposed method is able to identify relevant genes from raw expression profiles that are widely confirmed in the available literature. In order to rely on a large literature dataset, rather then performing manual searches, the literature has been mined resorting to the ProteinQuest bibliography data mining tool \[[@B25]\].

ProteinQuest is an advanced text-mining tool that exploits the web services offered by PubMed to perform advanced semantic searches of scientific papers. It searches for biological terms (e.g., diseases, proteins, genes, miRNAs, etc.) in titles and abstracts as well as in all image captions of all papers stored in Medline. Image captions are extracted, from free full-text articles, using the BFO Java library (<http://bfo.com/>) on the PDF version of the scientific papers \[[@B40]\]. ProteinQuest is capable of inheriting the PubMed MeSH terms indexing. ProteinQuest text-mining tool searches, in the abstracts and figure captions of all identified publications, for terms belonging to a manually curated protein dictionary based on Entrez MeSH terms. Common ambiguities in the terminology are resolved using a multiple search for more than one alias, as well as the cooccurrence of specific words, which can deny or force the tagging process.

ProteinQuest has been first used to manually refine the obtained lists of filtered genes in order to remove generic oncogenes that cannot be specifically ascribed to a selected disease. For instance, the AML\'s filtered genes contain TP53, a tumor suppressor protein crucial in multicellular organisms for cell cycle regulation \[[@B41]\]. TP53 is a clear example of a generic oncogene not specifically marking a particular cancer disease. To enhance the specificity of the network to the selected disease, it has been manually removed after filtering.

As a preliminary validation, we searched using ProteinQuest for all genes that have been cocited with one of the three available diseases submitting the query: "Leukemia, Myeloid, Acute" or "Breast Neoplasm" or "Lymphoma, Large B-Cell, Diffuse." The query is designed not to lose genes included in subsets such as phenotypes, and subtypes, by resorting to the most general keywords available for each disease. The query selected 10,488 genes extracted from 269,641 analyzed publications, and returned for each gene and for each disease the number of detected co-citations (global_citation_summary.xlsx file---Citation Data sheet---Columns A--D). For each disease, we sorted the list of 10,488 selected genes by their decreasing citation count, assigning to each gene a disease gene citation ranking (global_citation_summary.xlsx file---Citation Data sheet---Columns H--J). Top ranked genes are highly cocited with the disease. Finally, for each disease, we marked those genes present in the list of filtered genes obtained by our filtering algorithm. (global_citation_summary.xlsx file---Citation Data sheet---Columns E--G).

Starting from these citation data, [Figure 2](#fig2){ref-type="fig"} summarizes the preliminary validation performed for the AML dataset. Citation data have been filtered to select the AML filtered genes, only. Resulting data have been sorted by the AML citation rank and the citation rank of each selected gene for each of the three diseases has been plotted. The three citation ranks for each gene are always vertically aligned.

Looking at the left side of  [Figure 2](#fig2){ref-type="fig"}, one can notice that top ranked genes for the AML datasets (i.e., high number of co-citations between the gene and the disease) have, in general, a lower rank for the other two disease (i.e., lower number of co-citations), thus giving an indication that the genes selected by our algorithm have a higher bibliometric correlation with the selected disease. This selectivity decreases moving to lower ranked genes. It is worth to remember here that filtering was performed with a quite relaxed threshold that on the one hand limits the selectivity of the filtering process but, on the other hand, preserves low ranked genes that might be important to characterize specific phenotypes of the considered disease. This is, for example, the case for the diffuse large B-cell lymphoma. The considered dataset includes samples for two well-known phenotypes of this disease: (1) GC and (2) activated \[[@B37]\]. Thanks to the relaxed threshold, genes CD38, BCL7A, BCL6, MYB, PI3, CD2, CASP10 that are well known to be differentially expressed across the two phenotypes, even if not at the top of the ranked list, have been preserved in the filtered network, thus enabling to preserve this relevant information across the filtering process.

A similar trend is also confirmed looking at the citation data for the remaining two diseases reported in Figures [3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}.

In order to perform a more solid statistical validation through the use of bibliometric data, we executed a set of queries on ProteinQuest to understand if, given a disease, the set of genes selected by our algorithm is highly cocited with the disease while showing low citation count with the other diseases. As an example, [Algorithm 1](#alg1){ref-type="fig"} shows the query executed to search for citation relevance of AML genes with AML related publications. The query searches for papers in which at least one of the selected genes is cocited with the AML disease and not cocited either with BC or DLCL diseases. The query produces, for each gene, the number of papers in which the selected condition is respected.

Data obtained from the execution of these ProteinQuest queries have been aggregated in [Table 5](#tab5){ref-type="table"} that reports, for each group of filtered genes, the cumulative citation count for each disease. The full set of data returned by the execution of each query and used to construct [Table 5](#tab5){ref-type="table"} is available in the disease_citation_heatmaps.xlsx file provided as additional material of this paper. By construction, each query guarantees that citations obtained on each column of the table are disjoint.

We analyzed data reported in [Table 5](#tab5){ref-type="table"} using SAS software (version 9.1.3; SAS Institute, Cary, NC, USA). In order to find relationship between genes groups and diseases, frequencies of citations have been analyzed. For each group of genes, pairwise differences among diseases have been performed using the FREQ procedure. Furthermore, Bonferroni adjustment of the obtained *P* values has been carried out with the MULTTEST procedure.

The chi-square test reveals that citations frequencies among diseases (AML, DLCL, and BC) significantly differ by groups of selected genes (*χ* ~(4)~ ^2^ = 64,897.4; *P* \< 0.0001). Considering the first group of selected genes, the frequency of citations referred to AML (49.79%) significantly differs from both DLCL (*χ* ^2^ = 13,662; *P* \< 0.0001) and BC (*χ* ^2^ = 743.5; *P* ≤ 0.0001) citations (12.28% and 38%, resp.). Similarly, the proportion among citations in the second group of selected genes highlights significant differences between DLCL citations frequency (54.47%) and AML citations (13%; *χ* ^2^ = 6,496.5; *P* \< 0.0001) and between DLCL and BC citations (32.53%; *χ* ^2^ = 1,112.1; *P* \< 0.0001). Finally, greater frequency of citations has been observed in the third group of genes when comparing BC (83.92%) over AML (11.72%; *χ* ^2^ = 3,206.2; *P* \< 0.0001) and over DLCL (4.36%; *χ* ^2^ = 233,024; *P* \< 0.0001). The obtained results on frequencies of citations support the ability of the algorithm in selecting appropriate genes group according to the selected disease.

4. Conclusions {#sec4}
==============

In this paper we proposed a multi-weighted network topology, and a related algorithm for its analysis, that is able to filter complex coexpression networks obtained from gene expression data in order to reduce the network size and to retain only those genes and those interactions that are potentially related to a selected disease.

The algorithm has been tested on three public datasets for well-known studied diseases proving its high efficiency in reducing the complexity of the network. Moreover, to show that the filtering process is able to keep nodes, which are relevant for a particular disease, a validation campaign that resorts to bibliometric data mined through the ProteinQuest tool is presented.

The proposed approach represents a valuable starting point to reduce the complexity of complex biological networks in order to perform further analyses aiming at identifying interesting network motifs.

Supplementary Material {#supplementary-material-sec}
======================

###### 

Global citation summary.xlsx: This file integrates citation data for the three identified list of genes and correlates them with the related disease. These aggregated data enable to rank genes in a disease based on their citation count and to analyze the capability of our tool in selected genes that are highly cited in the literature with the related disease.

Disease_citation_heapmap.xlsx: This file reports raw citation data obtained using ProteinQuest to understand if, given a disease, the set of genes selected by our algorithm is highly cocited with the disease while showing low citation count with the other diseases. Data reported in this file are therefore obtained by running the query available in Algorithm 5 of the paper for the identified list of genes for the three considered diseases.

###### 

Click here for additional data file.
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![Example of construction of a MWNET. Expression data in this example are not from real experiments. They are simply used to show the process required to construct a MWNET starting from raw expression data.](BMRI2013-676328.001){#fig1}

![AML preliminary bibliometric validation.](BMRI2013-676328.002){#fig2}

![BC preliminary bibliometric validation.](BMRI2013-676328.003){#fig3}

![DLCL preliminary bibliometric validation.](BMRI2013-676328.004){#fig4}

![ProteinQuest query example to obtain citation data for the AML dataset.](BMRI2013-676328.alg.001){#alg1}

###### 

List of samples for the AML dataset. Samples are cDNA 45 K array technology.

  Sample number   GEO accession number   Experiment name
  --------------- ---------------------- -----------------
  1               GSM6259                AML 13
  2               GSM6266                AML 28
  3               GSM6281                AML 21
  4               GSM6284                AML 112
  5               GSM6309                AML 32
  6               GSM6317                AML 20
  7               GSM6318                AML 111
  8               GSM6319                AML 18
  9               GSM6275                AML 1
  10              GSM6285                AML 25
  11              GSM6292                AML 105
  12              GSM6311                AML 24
  13              GSM6335                AML 16
  14              GSM6337                AML 114

###### 

List of samples for the BC data-set. Samples are cDNA 9 K array technology.

  Sample number   GEO accession number   Experiment name
  --------------- ---------------------- --------------------------
  1               GSM73756               BC-16 versus NF (svi114)
  2               GSM73784               808A versus NF (svi060)
  3               GSM73706               107B versus NF (svi032)
  4               GSM73726               110B versus NF (svi033)
  5               GSM73727               111A versus NF (svi034)
  6               GSM73732               111B versus NF (svi035)
  7               GSM73734               114A versus NF (svi037)
  8               GSM73736               115B versus NF (svi038)
  9               GSM73783               710A versus NF (svi056)
  10              GSM73764               118B versus NF (svi041)
  11              GSM73786               123B versus NF (svi043)
  12              GSM73704               206A versus NF (svi045)
  13              GSM73708               214B versus NF (svi048)
  14              GSM73709               305A versus NF (svi049)
  15              GSM73738               308B versus NF (svi050)
  16              GSM73776               402B versus NF (svi052)
  17              GSM73777               406A versus NF (svi053)
  18              GSM73779               708B versus NF (svi054)
  19              GSM73697               805A versus NF (svi058)
  20              GSM73699               807A versus NF (svi059)

###### 

List of samples for the DLCL data-set. Samples are cDNA 9 K array technology.

  Sample number   GEO accession number   Experiment name
  --------------- ---------------------- -------------------------
  1               GSM2035                DLCL-0047
  2               GSM2036                DLCL-0042
  3               GSM1958                DLCL-0040
  4               GSM1959                DLCL-0036; OCT
  5               GSM2037                DLCL-0035
  6               GSM1994                DLCL-0034
  7               GSM2038                DLCL-0033
  8               GSM1995                DLCL-0032
  9               GSM1996                DLCL-0031
  10              GSM1997                DLCL-0030
  11              GSM1998                DLCL-0029
  12              GSM1960                DLCL-0028
  13              GSM1999                DLCL-0027
  14              GSM2039                DLCL-0026
  15              GSM2040                DLCL-0025
  16              GSM2000                DLCL-0024
  17              GSM2001                DLCL-0023
  18              GSM2041                DLCL-0021
  19              GSM2043                DLCL-0019
  20              GSM2044                DLCL-0018
  21              GSM2045                DLCL-0016
  22              GSM2047                DLCL-0014
  23              GSM2048                DLCL-0013
  24              GSM2049                DLCL-0012
  25              GSM2050                DLCL-0011
  26              GSM2051                DLCL-0010
  27              GSM2052                DLCL-0009
  28              GSM2053                DLCL-0008
  29              GSM2055                DLCL-0006
  30              GSM2056                DLCL-0005
  31              GSM2058                DLCL-0003
  32              GSM2059                DLCL-0002
  33              GSM2060                DLCL-0001
  34              GSM1965                DLCL-0052 *\|\|*lc4b060
  35              GSM1967                DLCL-0041 *\|\|*lc4b061
  36              GSM1968                DLCL-0039 *\|\|*lc4b039
  37              GSM1969                DLCL-0037 *\|\|*lc4b036
  38              GSM2072                DLCL-0034 *\|\|*lc8n109
  39              GSM1972                DLCL-0033 *\|\|*lc4b034
  40              GSM2073                DLCL-0032 *\|\|*lc8n110
  41              GSM2074                DLCL-0031 *\|\|*lc8n108
  42              GSM2016                DLCL-0028 *\|\|*lc7b025
  43              GSM2077                DLCL-0027 *\|\|*lc8n095
  44              GSM1974                DLCL-0025 *\|\|*lc4b059
  45              GSM2078                DLCL-0024 *\|\|*lc8n096
  46              GSM2079                DLCL-0023 *\|\|*lc8n098
  47              GSM1976                DLCL-0015 *\|\|*lc4b063
  48              GSM1977                DLCL-0011 *\|\|*lc4b030
  49              GSM1978                DLCL-0010 *\|\|*lc4b053
  50              GSM1979                DLCL-0009 *\|\|*lc4b027
  51              GSM1982                DLCL-0002 *\|\|*lc4b033

###### 

Aggregated filtering results for the three considered data-sets.

         Original number of genes   Filtered number of genes   Reduction ratio
  ------ -------------------------- -------------------------- -----------------
  AML    39,028                     505                        98.70%
  BC     7,531                      662                        91.20%
  DLCL   6,826                      115                        98.31%

###### 

Citations of groups of filtered genes according to the disease.

  Group of genes                 Disease              Total                          
  ------------------------------ -------------------- -------------------- --------- --------
  Number 1 AML filtered genes    23,248               5,741                17,769    46,758
  (49.72), \[63.68\]             (12.28), \[28.56\]   (38.00), \[17.56\]             
                                                                                     
  Number 2 DLCL filtered genes   2,470                10,347               6,180     18,997
  (13.00), \[6.77\]              (54.47), \[51.47\]   (32.53), \[6.11\]              
                                                                                     
  Number 3 BC filtered genes     10,787               4,015                77,223    92,025
  (11.72), \[29.55\]             (4.36), \[19.97\]    (83.92), \[76.33\]             
                                                                                     
  Total                          36,505               20,103               101,172    

( ): percentage in rows; \[ \]: percentage in columns.
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